hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang上一页:特发性癫痫大发作药物治疗的首选
下一页:综述:癫痫持续状态诊治最新进展
- 2022-05-05父母怎样分辨孩子是不是癫痫?出现这些症状,对学生不可大意!
- 2022-04-20哪些抗菌制剂可诱发癫痫?
- 2022-04-13癫痫治疗障碍仍难以克服
- 2022-04-12PLoS ONE:新的合成蛋白能快速激活免疫系统抵抗流感
- 2022-04-112013国际抗癫痫联合会抗癫痫药用指南
- 2022-04-07特发性癫痫大发作药物治疗的首选
- PLoS ONE:新的合成蛋白能快速激活免疫系统抵抗流感
- 综述:癫痫持续状态诊治最新进展
- 2013国际抗癫痫联合会抗癫痫药用指南
- 特发性癫痫大发作药物治疗的首选
- 预测癫痫患者再入院风险
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系
- 抗癫痫药物预防新发癫痫:任重而道远
- FDA批准Aptiom用于治疗患者癫痫发作
- 癫痫患者停药问题解决了吗?最新的预测模型已经发布!
- 三庚酸酯可治疗1型转运体缺陷综合征
- 癫痫猝死:凶手是谁?
- 治疗脑炎后遗症的方法有哪些?
- 癫痫症状 如何护理癫痫患者?
- 心理百科:春节期间小心疾病
- 2015第31届国际癫痫大会(IEC)
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 为什么要定期复查脑电图?
- 癫痫治疗 中医治疗癫痫不用担心
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- 2015 神经系统疾病诊疗进展
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- 月经性癫痫患者妊娠期癫痫控制更好
- 成人羊角风病的病因是什么?
- Medpage Today:不同类型的抗癫痫药物更有利
- 不注意这些问题,吃多少药都没用!
- 癫痫病的疗程费用
- 头上只手表就能测癫痫发作?智能穿头上设备太牛了
- 早期小儿癫痫病有什么患者
- 【健康辟谣日历】癫痫病人不能迎娶生子?
- 20130712养生:杨红开示癫痫病人不能吃什么
- 太原癫痫病医院:想要赶紧控制病情,这3大诊疗误区你一定要知道!
- 癫痫病有哪些哮喘呢
- 美国神经病学协会的新指南有助医生为HIV患者更好地选取癫痫药物
- 北京癫痫病专科医院治疗开支
- 延迟型癫痫发作患者卒中预后要好
- 最佳癫痫病治疗方法腹泻是什么
- 胶质瘤如何安全、精准全切?术中PETiMRI的重要意义
- 20120816cctv10健康之路:周文静说明了脑部结构